This HTML5 document contains 210 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q42653967
rdf:type
wikibase:Item
schema:description
artikulong pang-agham سائنسی مضمون vetenskaplig artikel naučni članak 2015 nî lūn-bûn научная статья 2015年學術文章 bilimsel makale artykuł naukowy наукова стаття, опублікована в січні 2015 სამეცნიერო სტატია 2015年学术文章 tudományos cikk vitskapeleg artikkel 2015년 논문 мақолаи илмӣ գիտական հոդված мақолаи илмӣ mokslinis straipsnis 2015年学术文章 מאמר מדעי vitenskapelig artikkel article scientific 2015年學術文章 ২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artículu científicu espublizáu en 2015 teaduslik artikkel artigo científico (publicado na 2015) article científic επιστημονικό άρθρο 2015年学术文章 2015年学术文章 articol științific artikull shkencor научни чланак مقالة علمية 2015年学术文章 2015年學術文章 artigo científico научна статия scientific article tieteellinen artikkeli vedecký článok videnskabelig artikel (udgivet 2015) 2015年の論文 2015年學術文章 articolo scientifico vědecký článek مقالهٔ علمی wetenschappelijk artikel научни чланак article scientifique (publié 2015) artigo científico (publicado na 2015) bài báo khoa học บทความทางวิทยาศาสตร์ artículo científico publicado en 2015 2015年學術文章 wissenschaftlicher Artikel scienca artikolo 2015年學術文章
p:P577
wds:Q42653967-BD881826-D14F-43C1-8099-1FABDB9955B5
wdt:P577
2015-01-01T00:00:00Z
p:P2860
wds:Q42653967-173EAD29-CA5F-46CE-ABE6-DA4EBD838BEB wds:Q42653967-196C8756-AE68-4FCA-8CE6-AFB2A002B155 wds:Q42653967-2915762B-1946-441E-AC96-772DACE2B281 wds:Q42653967-07648F4B-CD6E-484F-82FC-37DA57B2009A wds:Q42653967-1082F96B-FAA6-49A4-A7B2-83D5674D264C wds:Q42653967-136973F2-B927-4163-826E-5DD5F09D7ABF wds:Q42653967-3916542E-C2AE-4DD6-B223-D8C6C83A4B7A wds:Q42653967-469A8200-9923-4CEE-BDA8-F3C444D8F500 wds:Q42653967-2F3BEE89-B30D-44EC-AAC1-CF14ED0F7A0D wds:Q42653967-333CAA5A-A17A-4061-9498-F45D52BF174D wds:Q42653967-361F68E7-0DC3-40A2-8A9B-E01B97D7D620 wds:Q42653967-5F7EAFF3-9A74-4432-81DD-857A513D8186 wds:Q42653967-61D1A390-8853-40EA-B351-52256067D943 wds:Q42653967-64FA15F8-BBC5-4D58-9BFB-57D003378E9A wds:Q42653967-68BC98F6-79F7-440B-9ECD-469C3FC6046F wds:Q42653967-4EA4F451-787E-47DC-A94D-27CCD031DC60 wds:Q42653967-54791B57-6BDB-4EF0-B8CE-912F312FBF5D wds:Q42653967-57167D9E-7DF2-4DC7-A1BF-E509BFEB765B wds:Q42653967-5BB5C8DE-BEF7-4F29-BFB5-FABB102B551A wds:Q42653967-8825D2CD-E650-4B88-A9A5-9936B60951E8 wds:Q42653967-8ECA3E01-1BF6-45E2-A42F-49FCBB392328 wds:Q42653967-8F8D856B-63DD-49D0-9178-3B931FFE5651 wds:Q42653967-707D3EE4-ECA2-4920-AF33-3F177CA5DDE4 wds:Q42653967-A60D737A-C5E7-401D-90DB-1115F97FC477 wds:Q42653967-ACC72BA7-A554-4189-B478-A49F6D2EBDCD wds:Q42653967-B616AC23-C84A-45A5-9EAB-12797EB0E9FF wds:Q42653967-8FD0CEFB-8B3A-4FE6-8719-243A3059C422 wds:Q42653967-A2BE30C3-DE76-461C-AB2B-91614B7EF581 wds:Q42653967-A4830D5C-CF90-46DE-AB42-D446AC1DD4AA wds:Q42653967-BDA23B88-D8FD-4989-A5FD-D1F609F9841D wds:Q42653967-BE81FF55-B68B-4A48-B5E4-BC50966207BF wds:Q42653967-C07FAF9F-99C8-4995-9E49-8AA13B404C01 wds:Q42653967-C2328567-F030-473E-843F-11D71EF6E531 wds:Q42653967-B80851DC-2BCC-45C4-A09E-426B48B7C01B wds:Q42653967-B84B76B2-FBDF-4D5A-A2E2-842389692DEF wds:Q42653967-BB218C4C-2281-4C70-994E-6F903FD8E8E6 wds:Q42653967-D80D8282-0346-4E47-9B76-36BC6502AC5E wds:Q42653967-DE0BA014-19FB-41FA-86A1-3B234774DDD3 wds:Q42653967-C4A90CC1-5FEA-4ADD-8C73-96CAE1C8F119 wds:Q42653967-C6082449-9D93-43B2-951E-09D86B424FDB wds:Q42653967-E5DE5BC4-D8B5-42E5-867A-64AC82761164 wds:Q42653967-E8C2BD97-4D61-4E89-AD91-50796B346E29 wds:Q42653967-ECC72479-BF80-4A8D-920B-03AD9311810F wds:Q42653967-F3CB4AA1-2A9D-4852-8567-07274EBEE74B wds:Q42653967-FB392E26-CFC5-4C1D-9E03-657C3A4DB818 wds:Q42653967-FEFB0DDB-DA66-4558-AF31-CA796862A30D wds:Q42653967-F593A22C-8A2D-486C-A03A-ABA5E3FEFA43 wds:Q42653967-F6D18650-8C0E-4678-AEE7-17D310AF0E13 wds:Q42653967-F7172660-E3EC-42D2-94E2-FBED8567D25B
wdt:P2860
wd:Q45154904 wd:Q44256111 wd:Q46598257 wd:Q48178648 wd:Q37314324 wd:Q46938336 wd:Q51027720 wd:Q44801970 wd:Q51446410 wd:Q46732600 wd:Q46158758 wd:Q46607889 wd:Q42949755 wd:Q48126541 wd:Q83366773 wd:Q42958949 wd:Q46638446 wd:Q45114588 wd:Q51752502 wd:Q46457030 wd:Q46664291 wd:Q28300233 wd:Q48395243 wd:Q39210310 wd:Q38150584 wd:Q73134596 wd:Q35884425 wd:Q48348270 wd:Q48136465 wd:Q35561197 wd:Q28243960 wd:Q46868750 wd:Q42791895 wd:Q28249459 wd:Q80006324 wd:Q34398220 wd:Q80734962 wd:Q51749328 wd:Q44890537 wd:Q46897966 wd:Q48164407 wd:Q43793616 wd:Q48493079 wd:Q48693116 wd:Q87137265 wd:Q31157664 wd:Q35772807 wd:Q46315321 wd:Q38152648
p:P2093
wds:Q42653967-CBC7D958-15C4-4E32-8D5B-0B36394D2D90 wds:Q42653967-C56AE527-CC3D-42FD-AC8B-1227C159F991 wds:Q42653967-69F3F3C6-793F-4010-9EF0-05D42857E7E6 wds:Q42653967-8BBAB3E0-B326-489A-872C-5D35F97246EA wds:Q42653967-B18910D3-87FA-4AF3-A4A3-31DDCD9B1A92 wds:Q42653967-01DA5D47-D74E-4AD2-AD09-B3F8E46E40D2 wds:Q42653967-0881ACDA-32BD-4AFB-84BC-242959600819 wds:Q42653967-E2853618-D84E-4DC2-93C9-A6A5FC8E4A84 wds:Q42653967-E1BFD24E-4BF2-4ABA-8C46-C51D476AC764
wdt:P2093
Teresa Greco Roberto Dossi Gianluca Paternoster Daiana Taddeo Nikola Bradic Alessandro Belletti Tiziana Bove Andrea Matteazzi Ino Husedzinovic
rdfs:label
Beneficial impact of levosimendan in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials Beneficial impact of levosimendan in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials
skos:prefLabel
Beneficial impact of levosimendan in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials Beneficial impact of levosimendan in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials
schema:name
Beneficial impact of levosimendan in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials Beneficial impact of levosimendan in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials
p:P50
wds:Q42653967-E2A2242B-516D-400C-AE22-8A64A2C36159 wds:Q42653967-16ACE6FA-E6BD-4897-9757-F0DDE7845BE7 wds:Q42653967-DED7C522-295C-4E1F-BBF3-149C1B4416EA wds:Q42653967-7CFFFAA9-67BE-4444-B20A-990625A90FAB
wdt:P50
wd:Q73743453 wd:Q57081153 wd:Q57417332 wd:Q38546712
p:P1476
wds:Q42653967-3C2A0E03-E249-4378-89D4-2E0E1A8C83CE
wdt:P1476
Beneficial impact of levosimendan in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials
p:P304
wds:Q42653967-34BE98D1-ADDA-42F5-84F6-648A49E4C632
wdt:P304
35-46
p:P31
wds:Q42653967-7353D5AA-85C5-4299-97B5-04BEAE8B2643
wdt:P31
wd:Q13442814
p:P698
wds:Q42653967-FB0398D7-9449-46F2-8CB8-5F1CABEE1826
wdtn:P698
n8:25861589
wdt:P698
25861589
p:P1433
wds:Q42653967-A066A9ED-1B21-4C08-9E24-D4BEE322CC41
wdt:P1433
wd:Q26853783
p:P433
wds:Q42653967-D951E491-FA3F-453E-83CC-B2D1DFEDB6B1
p:P478
wds:Q42653967-3A18767A-8BEB-4640-B6D9-2D2697861937
wdt:P433
1
wdt:P478
7
p:P932
wds:Q42653967-E0296219-FA25-475B-9448-932BEA50E84A
wdt:P932
4381821